Slate of Candidates for BIO Health Section Governing Board 2013-2016 Term

  1. Adrian Adams, President & CEO, Auxilium Pharmaceuticals, Inc
  2. Daniel Apel, President & CEO, Bayer Healthcare, LLC
  3. Marc Beer, Chief Executive Officer, Aegerion Pharmaceuticals, Inc
  4. Jean-Jacques Bienaimé, Chief Executive Officer, BioMarin Pharmaceutical, Inc
  5. Alexis Borisy, Chairman, Foundation Medicine
  6. BJ Bormann, Senior Vice President and Global Head of Business Development, Boehringer Ingelheim Pharmaceuticals, Inc
  7. Ian Clark, CEO, Genentech,  Roche Group
  8. Ron Cohen, President & CEO, Acorda Therapeutics, Inc
  9. N. Anthony Coles, Chairman & CEO, Onyx Pharmaceuticals, Inc
  10. Stanley Crooke, Chairman & CEO, Isis Pharmaceuticals, Inc
  11. Douglas Doerfler, President & CEO, Maxcyte, Inc
  12. Roch Doliveux, Chairman & CEO, UCB
  13. Deborah Dunsire, President & CEO, Millennium: The Takeda Oncology Company
  14. Julie Gerberding, President, Merck Vaccines, Merck & Co., Inc
  15. Geno Germano, President and General Manager, Specialty Care and Oncology, Pfizer, Inc
  16. Glenn Gormley, President, Daiichi Sankyo Pharma Development
  17. Maxine Gowen, President & CEO, Trevena, Inc
  18. Peter Greenleaf, President, MedImmune, AstraZeneca, PLC
  19. Ludwig Hantson, Corporate Vice President and President, BioScience, Baxter International, Inc
  20. Paul Hastings, President & CEO, OncoMed Pharmaceuticals, Inc
  21. Russell Herndon, President & CEO, Hydra Biosciences, Inc
  22. Steven Holtzman, Executive Vice President, Corporate Development, Biogen Idec, Inc
  23. Hervé Hoppenot, President, Novartis Oncology, Novartis Pharmaceuticals, Inc
  24. James Hoyes, President, EMD Serono, Inc
  25. John Johnson, President, Chairman & CEO, Dendreon Corporation
  26. Daniel Junius, President & CEO, ImmunoGen, Inc
  27. Perry Karsen, Executive Vice President & COO, Celgene Corporation
  28. Rachel King, President & CEO, GlycoMimetics, Inc
  29. Scott Koenig, President & CEO, MacroGenics, Inc
  30. Jeffrey Leiden, President, Chair & CEO, Vertex Pharmaceuticals Incorporated
  31. John Leonard, Senior Vice President & Chief Scientific Officer, AbbVie
  32. Nick Leschly, chief bluebird, bluebird bio
  33. Jan Lundberg, Executive Vice President, Science and Technology, and President, Lilly Research Laboratories, Eli Lilly and Company
  34. Gordon McCauley, President & CEO, Allon Therapeutics, Inc
  35. James Manuso, Chairman & CEO, Astex Pharmaceuticals, Inc
  36. John Maraganore, Chief Executive Officer, Alnylam Pharmaceuticals, Inc
  37. Thomas Mathers, President & CEO, CoLucid Pharmaceuticals, Inc
  38. Russell Medford, President & CEO, Salutria Pharmaceuticals, LLC
  39. David Meeker, Chief Executive Officer, Genzyme, Sanofi
  40. Steven Mento, Co-Founder, President, Chairman & CEO, Conatus Pharmaceuticals, Inc
  41. Vincent Milano, President, Chairman & CEO, ViroPharma, Inc
  42. John Milligan, President & COO, Gilead Sciences, Inc
  43. Kenneth Moch, President & CEO, Chimerix, Inc
  44. Arlene Morris, Chief Executive Officer, Syndax Pharmaceuticals, Inc
  45. Mike Narachi, President & CEO, Orexigen Therapeutics, Inc
  46. Nicholas Nicolaides, Co-Founder, President & CEO, Morphotek, Inc
  47. John Orwin, Chief Executive Officer, Affymax, Inc
  48. Jonathan Peacock, Executive Vice President & CFO, Amgen Inc
  49. Kristine Peterson, Chief Executive Officer, Valeritas, Inc
  50. Richard Pops, Chairman & CEO, Alkermes, Inc
  51. David Pyott, Chairman & CEO, Allergan, Inc
  52. Howard Robin, President & CEO, Nektar Therapeutics
  53. Timothy Rodell, President & CEO, GlobeImmune, Inc
  54. Steven Ryder, President, Astellas Pharma Global Development, Inc
  55. Raymond Sacchetti, Sr. Vice President, U.S. Access & Government Affairs, Bristol-Myers Squibb
  56. Arthur Sands, President & CEO, Lexicon Pharmaceuticals, Inc
  57. David Schenkein, Chief Executive Officer, Agios Pharmaceuticals
  58. Jay Siegel,  Chief Biotechnology Officer & Head, Global Regulatory Affairs, Pharmaceuticals, Johnson & Johnson
  59. Mark Skaletsky, President & CEO, Fenway Pharmaceuticals, Inc
  60. Moncef Slaoui, Chairman, Research & Development, GlaxoSmithKline, plc
  61. Daniel Tassé, Chairman & CEO, Ikaria, Inc
  62. Henri Termeer, Chairman, AVEO Pharmaceuticals, Inc
  63. Gil Van Bokkelen, Chairman & CEO, Athersys, Inc
  64. Harold Van Wart, President, Director, & CEO, Metabolex, Inc
  65. Frank Verwiel, Chief Executive Officer, Aptalis Pharma US, Inc
  • Stephen Sherwin, Chair Emeritus (Non-Voting Member)
  • H. Thomas Watkins, Chair Emeritus (Non-Voting Member)